{"name":"Helixmith Co., Ltd.","slug":"helixmith-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Engensis","genericName":"Engensis","slug":"engensis","indication":"Other","status":"phase_3"},{"name":"High Dose VM202","genericName":"High Dose VM202","slug":"high-dose-vm202","indication":"Other","status":"phase_2"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Engensis (VM202)","genericName":"Engensis (VM202)","slug":"engensis-vm202","indication":"Critical limb ischemia (CLI) / peripheral arterial disease","status":"phase_3"}]}],"pipeline":[{"name":"Engensis","genericName":"Engensis","slug":"engensis","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Engensis (VM202)","genericName":"Engensis (VM202)","slug":"engensis-vm202","phase":"phase_3","mechanism":"VM202 is a plasmid DNA therapeutic that encodes hepatocyte growth factor (HGF) to promote angiogenesis and tissue repair in ischemic tissues.","indications":["Critical limb ischemia (CLI) / peripheral arterial disease","Diabetic foot ulcers"],"catalyst":""},{"name":"High Dose VM202","genericName":"High Dose VM202","slug":"high-dose-vm202","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxQRHJtakxvdkRYZ3J2azgyVWJiMVJpdDNZSFBQbEFfakVCcjZ0dUsydlVOMTlxa2pFdUdVengtendsdmJ2UG9nYzB5aVBJc1pYMmJwbnVkeTdlZ0xEMDRVVVBrYnFrN1lsNmo4VGlKdkdCSnV0c3VkdzlmRFluXzgtbmVNQURBNFpKa00tZDlWeXBod3hLR3ExTmpLbUxRTGFkMThDV0FmMk54VHJpeEhWbzRoSEhXVUlsYi1Ca2QyV3dPbWxvV0ZqMGFqbnN4Rk5Wd3N6ZUZ0dVR1MGpMdzF6eFhLN1l2a1MxbnFock1VU0ZMY0RHRTBHUmVB?oc=5","date":"2026-04-02","type":"trial","source":"Barchart.com","summary":"Motor Neuron Disease Clinical Trial Pipeline Shows Potential with Active Contributions from 180+ Key Companies | DelveInsight - Barchart.com","headline":"Motor Neuron Disease Clinical Trial Pipeline Shows Potential with Active Contributions from 180+ Key Companies | DelveIn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPZzhzNUV4V0FldDBxX1FvMzZhOEJoTzdlbUxyb3Jpc3dIMDFsX3NrM2ZIc1NNLTBKR0dmcVZ4ZmotRWREY0RVdEZ4ZXY2Z2h2X29aMGMwbHcyVUlDSV9JakU0YTdmSWFHdE1sOUxhR3Q3M2swa3V3cy05dEtUbHA0OTdPMVBac2ZBMWZ6dTMwT0x0RmN2NHc?oc=5","date":"2026-04-01","type":"pipeline","source":"openPR.com","summary":"Charcot-Marie-Tooth (CMT) Disease Market Size to Reach US$ - openPR.com","headline":"Charcot-Marie-Tooth (CMT) Disease Market Size to Reach US$","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AJBVV95cUxPdGJBeU96MEg2dHVQQmFFcXEycnA4LUtpajM5U3hqSkdTdWo1X1lqVkF2QXNPeG9YOHU5VWlUWmFVdXZ5aGc4YTB1SWtoNmlDWDJqVEdMbWh0Y3hvR3ZLTlZEM3k1SXJjRjB2Mmt5OS1yUVI2NlB3Vk5WZFRKNlRiYW1QclFjUFFESklTb0tfQlgxNVAyclhSNWZEeGR1dUhla21sRGxlZTcyQXZwTWdRdDBUa0lMb0YzRDNFanQxM0tESTI4Tkt1ZUxsQXFFY29yclFjc3FTbEF2MkxjWUV3aHRydWl0Nks3VzNSeTl1YlFTeW5sYTAtRVZkcEI0dmU2dEpkamRxT212Smk4d2ppQ25pN3NTMjhHUV9pZkVxRERxLXdKMlBKei1yUGphZFJiWXdQSEN6ckpKRllpWlJoRWFJUUJWc19rUXVwamJHc1VwWmU0?oc=5","date":"2025-06-05","type":"pipeline","source":"Barchart.com","summary":"Diabetic Peripheral Neuropathy Market on Track for Major Expansion by 2034, According to DelveInsight | Grünenthal, Averitas Pharma, Daiichi Sankyo, Vertex Pharma, Helixmith, Lexicon Pharma, Glenmark ","headline":"Diabetic Peripheral Neuropathy Market on Track for Major Expansion by 2034, According to DelveInsight | Grünenthal, Aver","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gJBVV95cUxNR3JCQnhRWFJKakk0Ykwxd25Za2xkR2lvY1ZPbGNUR29BaDZiaHZ5TWRZbmxUUm9RaXNPWFNjaFduVUw5NHBZRmZWQ01KYnUwNlVlRzg3UFVZcWJ4eFpzNHk1VGZLNDd4OWwzUllQRkIyZFNsVzB5UDBNd3Q3OGFMQllCR2NDczdtaXhETmhhM0swQ2oxT1NRRnlvdkRQbzRGLWFJX3BqTXRXcHQya3ctdFJEYlc0YlAwdFo0bW1TMFNTQUhSb01scmI2SFYwN3RISDhRUU9yazBLWklLMU9nbEJINGdaa3QtdTh3d0dYdHVnY3R1b2FEZDFWcGk2YkdqX25yOVVNUC1xOVRVWDVKcl80NGgwc0ZwZW9MLUJLYjFmWkl6T1NOT1hXQ1h4eVlNNTVLVU9pWDB4bFBLVUdiSEMzT0wyZ0ZVMERyTmdYanlXWGhwbGc?oc=5","date":"2024-11-13","type":"trial","source":"GlobeNewswire","summary":"NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears - GlobeNewswire","headline":"NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxPVkRMZTFPNWRnTEliZmx2X2haQUE0ZHJ6TWlGM1V4OElCRjVGMVE4VlpSN0NKLW5hd1pZbHR3QWFQbU1NUHAyWldwd0ZaTVpMY1ZBaFlWU3ZZbHpZVkJsRUtEWnB6XzIyTFlPRGdYVmpHakR6RUVWdWxVcnppcm9neEtOaGIwT0lUZnFrWXJ4TmhuVlZlU1pUcEl2X0Z3VERmdW1ydXA1RmR3WkxqZUtwTUpYTkFISU94YjRYSGRCZnNfaUhRV1l3SzhIN29yd1hGblhqa2lVOEFLMXlxeU1FUVo5clhTY1JpMjUzbFpyOFVxMGctczBwZlZNTjJJMjgwSnppaGM1T2pJbjdBckV4ZnRtTTZVVUl1cG1mS1hlX2w?oc=5","date":"2024-10-22","type":"trial","source":"GlobeNewswire","summary":"Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ - GlobeNewswire","headline":"Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5uQlNBMjRIN21SUVFta3F5OXoxcXlnVjRhSDNVNU90YkF5WmowQjh5T0lSbTQ3NEg1ejBfV2NwMzVhNHN3dDhwQ3hsc1dtSU12dXQ3RldfQnViVjAwQ2VWWk5iV0NNTFMtNFI5eDl30gFyQVVfeXFMT3VXNzBUYzNESGtIZXhJdnBudUNsank0YzZpU2Y0cDhpQVRmVlVhZnAwOWVvM0hfdjJ0QzN5ZEVGOGRQdW5ydEppR1RqMG1JS0k2Rk8zNTdXdmVBMXBSM2x4eldYbXNnNEpoLTA4UVpDaHFB?oc=5","date":"2024-01-03","type":"trial","source":"koreabiomed.com","summary":"Helixmith's gene therapy fails phase 3 trial for diabetic peripheral neuropathy - koreabiomed.com","headline":"Helixmith's gene therapy fails phase 3 trial for diabetic peripheral neuropathy","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPc0ZRc1F0cUhrY0RVdTczMUhmOUtCaC1JcGs4dGpEUEVrWmFpOGM1VURoNldNWEd5WXJhM1BTTXBJaVlBOUVJcmd5WHdPWjZiVWxuNWFMdUh0RUFkLUM0RG5sRl8yNjBMcHBBQnBkdzRDZGVVMnc2MjRKeTVmbTdWLVZOaF93Z2s?oc=5","date":"2023-09-18","type":"pipeline","source":"Yahoo Finance","summary":"Charcot-Marie-Tooth Disease Market Size and Share to Grow by 2032, Predicts DelveInsight | Key Players in the Market - Pharnext, MedDay, HELIXMITH, ENCell, InFlectis, Addex, Augustine, DTx Pharma - Ya","headline":"Charcot-Marie-Tooth Disease Market Size and Share to Grow by 2032, Predicts DelveInsight | Key Players in the Market - P","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE41UEJ5TGRCZVZHVWxSdWlpd1FEa3B4S2NGbktNMGZ2cHJVWUxVbldNdDhNOEN2aWY1d0I2bUlOX1Nma3V0cXU5MHB1ekRUYjdYSU1ZX2NvMWZJbk43bHYxY0ZYU1hDTW5UTjEwetIBcEFVX3lxTFBPdy1LYXRxZXBEX19yNXp6SmRBVWktNVdxN0pDOFR1RUdBMzJCV3NVV01OU2dPZHVGUUVEcnpsV2d0M19fQ1pBQnhoeTRnV2ViMjNCLUJ4ZUNNR0p3S3VSSGdRdGczVmV0eWpJZmkydWY?oc=5","date":"2020-09-14","type":"pipeline","source":"koreabiomed.com","summary":"Helixmith spins off 2 projects as subsidiaries - koreabiomed.com","headline":"Helixmith spins off 2 projects as subsidiaries","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPR0Qta1ltdEs5STBpamE3QlR4clBPc3BmckhuM3lqYWlQbDhsRGtvS3RmV3drMjYzZTZyQW9QT0xlWnN2YU9LQU1BRU5vek5GSloyUFBPcThzWlZ0YTd5Z0gtVUlqUy0tQ1RSTWJHSVI2R1dSOUNHcDY2UmM2cDByOE1DMnN5X3RRejRQY2pZQXVrN2I0RVpteVllcnVaX2s0VUNMeVdwcDh6T0VyU3pjN1Zn?oc=5","date":"2020-06-08","type":"pipeline","source":"Bloomberg.com","summary":"Short-Sellers Set Their Sights on Surging Asia Biotech Stocks - Bloomberg.com","headline":"Short-Sellers Set Their Sights on Surging Asia Biotech Stocks","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":2,"phase_2":1},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}